Cargando…

Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study

To investigate whether cerebrospinal fluid (CSF) markers differ between pediatric-onset multiple sclerosis (PoMS, onset < 18 years) and adult-onset (AoMS), and whether these markers are associated with clinical outcomes among PoMS. Prospective nationwide registry study of incident MS, including p...

Descripción completa

Detalles Bibliográficos
Autores principales: McKay, Kyla A., Wickström, Ronny, Hillert, Jan, Karrenbauer, Virginija Danylaite
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448868/
https://www.ncbi.nlm.nih.gov/pubmed/34535701
http://dx.doi.org/10.1038/s41598-021-97543-6
_version_ 1784569327979069440
author McKay, Kyla A.
Wickström, Ronny
Hillert, Jan
Karrenbauer, Virginija Danylaite
author_facet McKay, Kyla A.
Wickström, Ronny
Hillert, Jan
Karrenbauer, Virginija Danylaite
author_sort McKay, Kyla A.
collection PubMed
description To investigate whether cerebrospinal fluid (CSF) markers differ between pediatric-onset multiple sclerosis (PoMS, onset < 18 years) and adult-onset (AoMS), and whether these markers are associated with clinical outcomes among PoMS. Prospective nationwide registry study of incident MS, including persons with a CSF sample < 3 years post-MS onset. We compared CSF oligoclonal band (OCB) status, immunoglobulin G (IgG) index levels, and mononuclear cell count between PoMS and AoMS. Within the PoMS cohort we analyzed the association between CSF markers, relapse rate and Expanded Disability Status Scale (EDSS) score, using negative binomial regression and generalized estimating equations, respectively. The cohort consisted of 130 PoMS and 3228 AoMS cases. The PoMS group had higher odds of OCB-positivity (odds ratio: 2.70; 95% CI 1.21–7.67). None of the CSF markers were associated with relapse rate in the PoMS cohort; however, OCB-positivity was associated with higher EDSS scores. This study suggested that PoMS more commonly display CSF evidence for intrathecal IgG production than AoMS. Further, we found evidence of a relationship between OCB-positivity and subsequent disability, suggesting that they could play a role in the prognostication of MS in children.
format Online
Article
Text
id pubmed-8448868
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84488682021-09-21 Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study McKay, Kyla A. Wickström, Ronny Hillert, Jan Karrenbauer, Virginija Danylaite Sci Rep Article To investigate whether cerebrospinal fluid (CSF) markers differ between pediatric-onset multiple sclerosis (PoMS, onset < 18 years) and adult-onset (AoMS), and whether these markers are associated with clinical outcomes among PoMS. Prospective nationwide registry study of incident MS, including persons with a CSF sample < 3 years post-MS onset. We compared CSF oligoclonal band (OCB) status, immunoglobulin G (IgG) index levels, and mononuclear cell count between PoMS and AoMS. Within the PoMS cohort we analyzed the association between CSF markers, relapse rate and Expanded Disability Status Scale (EDSS) score, using negative binomial regression and generalized estimating equations, respectively. The cohort consisted of 130 PoMS and 3228 AoMS cases. The PoMS group had higher odds of OCB-positivity (odds ratio: 2.70; 95% CI 1.21–7.67). None of the CSF markers were associated with relapse rate in the PoMS cohort; however, OCB-positivity was associated with higher EDSS scores. This study suggested that PoMS more commonly display CSF evidence for intrathecal IgG production than AoMS. Further, we found evidence of a relationship between OCB-positivity and subsequent disability, suggesting that they could play a role in the prognostication of MS in children. Nature Publishing Group UK 2021-09-17 /pmc/articles/PMC8448868/ /pubmed/34535701 http://dx.doi.org/10.1038/s41598-021-97543-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
McKay, Kyla A.
Wickström, Ronny
Hillert, Jan
Karrenbauer, Virginija Danylaite
Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
title Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
title_full Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
title_fullStr Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
title_full_unstemmed Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
title_short Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
title_sort cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448868/
https://www.ncbi.nlm.nih.gov/pubmed/34535701
http://dx.doi.org/10.1038/s41598-021-97543-6
work_keys_str_mv AT mckaykylaa cerebrospinalfluidmarkersinincidentpediatriconsetmultiplesclerosisanationwidestudy
AT wickstromronny cerebrospinalfluidmarkersinincidentpediatriconsetmultiplesclerosisanationwidestudy
AT hillertjan cerebrospinalfluidmarkersinincidentpediatriconsetmultiplesclerosisanationwidestudy
AT karrenbauervirginijadanylaite cerebrospinalfluidmarkersinincidentpediatriconsetmultiplesclerosisanationwidestudy